Teledyne wins award for device to improve fire resistance of offshore well heads
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen gets FDA approval for Blincyto
Shares for Amgen ticked up 50 cents after the company announced March 29 that its cancer drug Blincyto had received U.S. Food and Drug Administration approval to treat patients in their first or second remission. The decision makes Blincyto the first therapy to be approved to treat patients with minimal residual disease, or MRD, the Read More →
Teledyne Technologies lands big contract in Kuwait
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
European regulators have good news for Amgen
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Irwin co-authors bill to establish redevelopment agencies to fund affordable housing
Assemblymember Jacqui Irwin (D-Thousand Oaks) is a co-author of a bill to allow cities to establish redevelopment housing and infrastructure agencies to fund affordable housing and infrastructure projects in California, according to a March 22 news release. The bill, AB 3037, would reinvent redevelopment agencies that were eliminated in 2011. At the time of their Read More →